Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products and medical devices worldwide. It offers various ethical drugs, including Closerin for active pulmonary and extra-pulmonary tuberculosis; Dulastin and Leucostim for neutropenia in patients receiving myelosuppressive chemotherapy; Eporon for anemia associated with chronic renal failure; Gemcit for non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin for infertility and annovulation; Growtropin II for growth failure due to an inadequate secretion of growth hormone and idiopathic short stature; Mainta for non-small cell lung cancer and malignant pleural mesothelioma; Monotaxel for breast, non-small cell lung, prostate, head, and neck cancers, as well as gastric adenocarcinoma; Motilitone for use in functional dyspepsia treatment; Stillen for the treatment of gastritis; Suganon for diabetes treatment; Terizidone for active pulmonary and extra-pulmonary tuberculosis; and Zydena for erectile dysfunction treatment. The company also provides licensed-in and licensed-out drugs; and medical devices, which cover high technology medical devices, custom made products, and sets of artificial cardiac circuits for use in open-heart surgery. Dong-A ST Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.

Metric
Company Name	Dong-A ST Co., Ltd.
Symbol	170.90K
MSH ID	COM:DONGA-ST
Market	STOCKS
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Country	KR
Stage
Employee Count	1.66K
Website	donga-st.com
LinkedIn	%EB%8F%99%EC%95%84st
Founders

Metric
Market Cap	405.85M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	466.47M
Revenue (LTM)
Revenue (NTM)
Gross Profit	226.37M
EBITDA	26.36M
Operating Income	7.85M
Net Income	7.81M
EPS	0.90
Diluted EPS	0.77
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.49
Operating Profit Margin	0.02
EBITDA Margin	0.06
Net Profit Margin	0.02
Return on Equity	0.02
Return on Assets	0.01
Return on Capital Employed	0.01

1709

COM:DONGA-ST

DongA ST Co., Ltd.

Last Close

61,700.00

25/11 06:30

Market Cap

577.53B

Beta: -

Volume Today

32.25K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	127.07
P/B Ratio	0.84
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.05
EV Multiple	5.18

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding	132.15
Operating Cycle	211.20
Cash Conversion Cycle	170.59
Asset Turnover	0.51

Metric
Operating Cash Flow	1.70M
Free Cash Flow	-27.91M
Cash Flow to Debt	0.01
Operating Cash Flow/Sales	0.00
Free Cash Flow Yield	-0.10

Metric
Cash & Equivalents	149.47M
Accounts Receivable	-8.79M
Inventory	81.71M
Goodwill	29.64M
Debt to Capitalization	0.48
Debt to Assets
Current Ratio	1.83
Quick Ratio	1.41

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.00
R&D to Revenue	0.12
SG&A to Revenue	0.37